|
C18ORF25 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.194380E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.684400E-01 |
| Normal-vs-Stage2 |
5.960800E-01 |
| Normal-vs-Stage3 |
2.167900E-04 |
| Normal-vs-Stage4 |
2.44220000000794E-06 |
| Stage1-vs-Stage2 |
9.228400E-01 |
| Stage1-vs-Stage3 |
5.564100E-04 |
| Stage1-vs-Stage4 |
3.89990000004836E-06 |
| Stage2-vs-Stage3 |
4.684300E-02 |
| Stage2-vs-Stage4 |
7.880800E-03 |
| Stage3-vs-Stage4 |
2.981400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.246130E-02 |
| Normal-vs-AfricanAmerican |
2.628300E-02 |
| Normal-vs-Asian |
5.059000E-01 |
| Caucasian-vs-AfricanAmerican |
4.784000E-01 |
| Caucasian-vs-Asian |
1.003020E-01 |
| AfricanAmerican-vs-Asian |
7.397700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.943400E-03 |
| Normal-vs-Female |
1.500560E-01 |
| Male-vs-Female |
1.881440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.196400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.893800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.557500E-04 |
| Normal-vs-Age(81-100Yrs) |
2.004000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.528760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.631800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.295600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.460380E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.283600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.750000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.290300E-02 |
| Normal-vs-Grade 2 |
7.721400E-01 |
| Normal-vs-Grade 3 |
7.821600E-04 |
| Normal-vs-Grade 4 |
1.50540000465327E-08 |
| Grade 1-vs-Grade 2 |
1.269820E-01 |
| Grade 1-vs-Grade 3 |
1.798630E-03 |
| Grade 1-vs-Grade 4 |
2.18620000003167E-06 |
| Grade 2-vs-Grade 3 |
7.022800E-04 |
| Grade 2-vs-Grade 4 |
5.88869997208974E-09 |
| Grade 3-vs-Grade 4 |
1.797720E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.894600E-01 |
| Normal-vs-ccB subtype |
2.575700E-04 |
| ccA subtype-vs-ccB subtype |
7.1400000001276E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.762200E-02 |
| Normal-vs-N1 |
1.400450E-02 |
| N0-vs-N1 |
2.998400E-01 |
|
|
